Release Date: 27/11/14 16:26 Summary: Update to Shareholders - Sale of Business Price Sensitive: No Download Document 67.57KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%